Postradiotherapy hypothyroidism: Radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy

Journal of Surgical Oncology

Volumn 61, Issue 4, 1996, Pages 281-283

  Kuten, Abraham ^a,c   Lubochitski, Rafael ^b,c   Fishman, Gadi ^a,c   Dale, Janet ^d   Stein, Moshe E ^a,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

chemo radiotherapy; head and neck carcinoma; Hodgkin's disease; hypothyroidism

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; THYROTROPIN; VINBLASTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIZATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HODGKIN DISEASE; HUMANS; HYPOTHYROIDISM; IATROGENIC DISEASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 0029942488     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199604)61:4<281::AID-JSO10>3.0.CO;2-9     Document Type: Article

References (15)

1. Peerboom PF, Hassink EAM, Melkert R, et al.: Thyroid dysfunction 10-18 years after mantle field irradiation for Hodgkin's disease. Eur J Cancer 10:1716-1718, 1991.
2. Bookman MA, Longo DI: Concomitant illness in patients treated for Hodgkin's disease. Cancer Treat Rev 13:77-111, 1986.
3. Grande C: Hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors. Radiother Oncol 25:31-36, 1992.
4. Kaplan MM, Garnick MB, Gelber R, et al.: Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 74:272-280, 1983.
5. Wittes RE: Endocrine system. In Wittes RE [ed]: "Oncologic Therapeutics 1991-1992." Philadelphia: Lippincott, 1991, p 221-224.
6. Schroeder SA, Krupp MA, Tierney LM, et al.: Current medical diagnosis and treatment. Prentice-Hall International, 1990.
7. Kalistratova VS: The relation of non-stochastic effects to the radiation dose of the human thyroid gland. Vestnik Akademii Meditinskikh Nauk Sssr 43-47, 1992.
8. Tami TA, Gomez P, Parker GS, et al.: Thyroid dysfunction after radiation therapy in head and neck cancer patients. Am J Otolaryngol 13:357-362, 1992.
9. Weissler MC, Berry BW: Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 13:420-423, 1991.
10. Liening DA, Duncan NO, Blakeslee DB, et al.: Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 103:10-13, 1990.
11. Buisset E, Leclerc L, Lefebvre JL, et al.: Hypothyroidism following combined treatment for hypopharyngeal and laryngeal carcinoma. Am J Surg 162:345-347, 1991.
12. Hancock SL, McDougall IR, Constine LS: Thyroid abnormalities after therapeutic external radiation. Int J Rad Oncol Biol Phys 31:1165-1170, 1995.
13. Constine LS, Donaldson SS, McDougall IR: Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 53:878-883, 1984.
14. Smith RE, Adlen RA, Clark P, et al.: Thyroid function after mantle irradiation in Hodgkin's disease. JAMA 245:46-49, 1981.
15. Green DM, Brecken ML, Yakar D, et al.: Thyroid function in pediatric patients after neck irradiation for Hodgkin's disease. Med & Ped Oncol 8:127-136, 1980.